Limited Market Potential of Boxed CBD Pouches at Dortmund Exhibition.

Sep.21.2024
Limited Market Potential of Boxed CBD Pouches at Dortmund Exhibition.
A new boxed CBD pouch product was showcased at Dortmund Tobacco Expo with a higher price point and uncertain market potential.

At this year's Dortmund tobacco expo, 2Firsts witnessed a vendor displaying a boxed CBD pouch product. Onsite staff mentioned that the target audience for this product is similar to that of nicotine pouches. However, the expo organizers revealed that due to the relatively high price of boxed CBD pouch products, it is expected to be double the price of nicotine pouches, which will to some extent affect its market positioning and consumer demographics selection.


According to the exhibitors, the product currently has very low sales in the market, and it is even difficult to pinpoint its main sales market. Despite the product being fully developed, the brand is not optimistic about its future market prospects, and even believes that boxed CBD bag products do not have a wide market space. They admit that due to poor current sales performance, the brand may not promote or sell this product on a large scale in the future.


Despite this, the exhibitor still showcased the product but had reservations about canned CBD pouch products, believing their market potential to be limited.


According to reports, CBD is short for Cannabidiol, a compound found in cannabis that does not have addictive or hallucinogenic effects on users. It is often used to alleviate symptoms such as anxiety, pain, insomnia, and epilepsy, and can be consumed in various forms including oil, capsules, gummies, and topicals. Currently, there are strict regulations in place in many places regarding the use, sale, and production of CBD.


We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

China Tobacco Hong Kong 2025 Interim Results: Revenue HKD 10.3 billion, up 18.5% year-on-year; New Tobacco Export Business Revenue HKD 14.6 million, down 66.5% year-on-year
China Tobacco Hong Kong 2025 Interim Results: Revenue HKD 10.3 billion, up 18.5% year-on-year; New Tobacco Export Business Revenue HKD 14.6 million, down 66.5% year-on-year
China Tobacco International (Hong Kong) recorded revenue of HKD 10.32 billion in the first half of 2025, up 18.5% year-on-year, with gross profit down 1.8%. Net profit attributable to shareholders was HKD 706 million, up 9.8% year-on-year. Revenue from the new tobacco export business was HKD 14.6 million, down 66.5% year-on-year.
Aug.22 by 2FIRSTS.ai
Philip Morris International to Boost Investment in the Philippines, Aiming to Make It a Smoke-Free Products Export Hub
Philip Morris International to Boost Investment in the Philippines, Aiming to Make It a Smoke-Free Products Export Hub
PMI to make the Philippines a smoke-free export hub, citing strong regulation; upgrading local plants, expanding affordable supply; $14bn invested globally.
Oct.11 by 2FIRSTS.ai
Study Reveals Vuse’s Social Media Marketing: Using F1 and Influencers to Circumvent Advertising Bans through Entertainment Marketing
Study Reveals Vuse’s Social Media Marketing: Using F1 and Influencers to Circumvent Advertising Bans through Entertainment Marketing
A new study reveals that BAT-owned Vuse leverages global social media accounts for marketing, expanding its influence through F1 partnerships and influencer-driven entertainment placements to circumvent advertising bans. The study highlights insufficient compliance transparency and calls for strengthened unified global regulation.
Aug.19 by 2FIRSTS.ai
2Firsts Exclusive: Dr. Zdinak Analyzes FDA’s Rejection of blu, Citing Lack of Behavioral Evidence
2Firsts Exclusive: Dr. Zdinak Analyzes FDA’s Rejection of blu, Citing Lack of Behavioral Evidence
In a 2Firsts exclusive, ARAC’s Dr. Zdinak explains FDA’s blu rejection stems from weak behavioral science data and urges companies to strengthen Module 6 studies immediately.
Aug.20
InterTabac 2025 Insights|RELX Unveils “Vaporless” Showcase Cabinet Featuring Nicotine Airpouch and Prototype Vaporless Device
InterTabac 2025 Insights|RELX Unveils “Vaporless” Showcase Cabinet Featuring Nicotine Airpouch and Prototype Vaporless Device
At InterTabac 2025, RELX’s oral-nicotine showcase featured leaf-shaped Nicotine Airpouch products under the WAKA, RELX, and DOSH brands, alongside a prototype “vaporless oral product.” The device produces no visible aerosol upon exhalation during light puffs and is currently for exhibition only, with no confirmed launch timeline. RELX also displayed a nose-inhaled e-cigarette that differs from conventional mouth-inhaled vaping by requiring nasal inhalation.
Sep.20 by 2FIRSTS.ai
Thailand's Senate and House of Representatives have different stances on e-cigarettes: the Senate advocates a ban on sales, while the House of Representatives proposes legalization and regulation
Thailand's Senate and House of Representatives have different stances on e-cigarettes: the Senate advocates a ban on sales, while the House of Representatives proposes legalization and regulation
Recently, the Thai Senate and House of Representatives submitted research reports on e-cigarettes, but their positions were completely opposite. The report of the Senate Public Health Committee insisted on maintaining a complete ban on the import and sale of e-cigarettes, emphasizing the protection of public health, especially youth health, while the report of the House of Representatives Special Committee proposed to legalize e-cigarettes under a strict regulatory framework.
Sep.25 by 2FIRSTS.ai